Ventricular Tachycardia Clinical Trial
Official title:
Ventricular Tachycardia Substrate Mechanisms Revealed by Local Repolarization and Conduction Parameters
The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.
Ventricular tachycardia (VT) ablation remains the cornerstone treatment for drug refractory VT. Previous studies have reported success rate of VT ablation ranging from 23 to 49%. Despite improvements in mapping and catheter technology, there is a high recurrence rate and numerous patients who fail VT ablation. Reasons for failure in VT ablation include the inability to identify critical areas of myocardium responsible for VT and hemodynamic instability of VT during mapping. Several studies have attempted to study electrical properties of cardiac tissues to identify potential circuits in sinus rhythm avoid mapping during unstable VT. This includes mapping fractionated electrical potentials, isochronal late activation mapping (ILAM), and ablation of low voltage regions. However, these techniques have yielded modest improvement in success rates with poor specificity of identifying important regions. Monophasic action potentials (MAP) demonstrate cellular action potential of the myocardium. Recent evidence suggests that changes in MAP morphology can predict sudden cardiac death by ventricular arrhythmias. However, cellular activation has not been studied in VT. The researchers of this study propose that MAP signals can better elucidate electrophysiological characteristics of the myocardium, and thus identify sites critical to VT. During a standard of care VT ablation, the researchers will use the MAP catheter to study cellular action potential of the ventricular myocardium, which cannot be done on traditional catheters. The design of this catheter is similar to other diagnostic catheters that are currently used for VT ablation. The MAP catheter is a bipolar catheter, two with electrical poles at the distal tip. The catheter is placed on the myocardium (similar to other traditional catheters) and a recording signal is transmitted to the workstation. Using the MAP catheter the will not interrupt or distort any of the standard treatment procedures. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03453645 -
Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
|
||
Completed |
NCT05970120 -
A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter
|
N/A | |
Completed |
NCT05791032 -
Sub Chronic Evaluation for ATP With an Extravascular Placed ICD Lead (STEP ICD) Study
|
N/A | |
Completed |
NCT04011631 -
Evaluation of the iD-SystemTM, One-Handed Disposable Internal Defibrillation System.
|
N/A | |
Recruiting |
NCT03536052 -
Ablation at Virtual-hEart pRedicted Targets for VT
|
N/A | |
Not yet recruiting |
NCT06063811 -
Ventricular Tachycardia Ablation in LVAD Patients
|
||
Enrolling by invitation |
NCT02962076 -
Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia
|
Early Phase 1 | |
Not yet recruiting |
NCT02784912 -
Biomarkers in Risk Stratification of Sustainted Ventricular Tachycardia or Electrical Storm After Ablation
|
N/A | |
Completed |
NCT01791543 -
Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
|
N/A | |
Terminated |
NCT02891863 -
Low Energy Therapy to Convert Ventricular Tachycardias
|
Phase 0 | |
Terminated |
NCT01546207 -
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
|
N/A | |
Completed |
NCT01294267 -
Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation
|
N/A | |
Terminated |
NCT00383799 -
Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
|
Phase 4 | |
Completed |
NCT04884100 -
enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening
|
N/A | |
Completed |
NCT04642963 -
Stereotactic Management of Arrhythmia - Radiosurgery in Treatment of Ventricular Tachycardia
|
N/A | |
Recruiting |
NCT05377216 -
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
|
Early Phase 1 | |
Not yet recruiting |
NCT04990089 -
VIVO European Observational Registry
|
||
Completed |
NCT04065893 -
Impact of Catheter Ablation of Ventricular Arrhythmias on Suboptimal Biventricular Pacing in Cardiac Resynchronization Therapy
|
||
Recruiting |
NCT03631303 -
Post-Extrasystolic Potentiation as a Predictor of Ventricular Arrhythmias
|
||
Recruiting |
NCT03611465 -
Creation of a Pace-mapping Atlas on Healthy and Pathological Hearts
|
N/A |